BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
7 hedge funds and large institutions have $2.67M invested in BriaCell Therapeutics Corp Warrant in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.
1.5% more ownership
Funds ownership: 7.54% → 9.04% (+1.5%)
13% less funds holding
Funds holding: 8 → 7 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
56% less capital invested
Capital invested by funds: $6.02M → $2.67M (-$3.36M)
73% less call options, than puts
Call options by funds: $813K | Put options by funds: $3.01M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
+$622K |
| 2 |
M
Murchinson
Toronto,
Ontario, Canada
|
+$180K |
| 3 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$67.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$84K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$83K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
M
1
Murchinson
Toronto,
Ontario, Canada
| $1.37M | +$180K | +56,297 | +12% |
|
|
PFM
2
Privium Fund Management
Amsterdam,
Netherlands
| $507K | +$622K | +194,817 | New |
|
|
KJHP
3
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| $472K | +$67.7K | +21,219 | +13% |
|
|
RAM
4
Redmond Asset Management
Henrico,
Virginia
| $190K | – | – | – |
|
|
ZCA
5
Zeke Capital Advisors
Berwyn,
Pennsylvania
| $117K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $13K | +$12.6K | +3,936 | +346% |
|
|
AC
7
Armistice Capital
New York
| $975 | – | – | – |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$84K | -16,092 | Closed |
|
|
WAM
9
Warberg Asset Management
Winnetka,
Illinois
| – | -$83K | -16,046 | Closed |
|
BCTXW Hedge Fund Activity: Q2 2022 in Review
7 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q2 2022, worth a combined $2.67M — down 56% from $6.02M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BCTXW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.
The largest buyer was Privium Fund Management, opening a new position worth an estimated $622K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $84K sold.
- 7 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q2 2022, down from 8 in Q1 2022.
- Funds reported $2.67M of BriaCell Therapeutics Corp Warrant stock for Q2 2022, down 56% quarter-over-quarter.
- 1 fund opened new BriaCell Therapeutics Corp Warrant positions in Q2 2022 and 2 closed out, a net change of -1 holder.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q2 2022 was Privium Fund Management, an estimated $622K added.
- The largest BriaCell Therapeutics Corp Warrant seller in Q2 2022 was Susquehanna International Group, an estimated $84K sold.
Based on aggregated 13F filings for Q2 2022.